Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Curr Alzheimer Res ; 9(7): 815-21, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21605064

RESUMO

Brain-derived neurotrophic factor (BDNF) is a growth factor implicated in neuronal survival. Studies have reported altered BDNF serum concentrations in patients with Alzheimer's disease (AD). However, these studies have been inconsistent. Few studies have investigated BDNF concentrations across multiple neurodegenerative diseases, and no studies have investigated BDNF concentrations in patients with frontotemporal dementia. To examine BDNF concentrations in different neurodegenerative diseases, we measured serum concentrations of BDNF using enzyme-linked immunoassay in subjects with behavioral-variant frontotemporal dementia (bvFTD, n=20), semantic dementia (SemD, n=16), AD (n=34), and mild cognitive impairment (MCI, n=30), as well as healthy older subjects (HS, n=38). BDNF serum concentrations were compared across diagnoses and correlated with cognitive tests and patterns of brain atrophy using voxelbased morphometry. We found small negative correlations between BDNF serum concentrations and some of the cognitive tests assessing learning, information processing speed and cognitive control in complex situations, however, BDNF did not predict disease group membership despite adequate power. These findings suggest that BDNF serum concentration may not be a reliable diagnostic biomarker to distinguish among neurodegenerative diseases.


Assuntos
Doença de Alzheimer/diagnóstico , Fator Neurotrófico Derivado do Encéfalo/sangue , Disfunção Cognitiva/diagnóstico , Demência Frontotemporal/diagnóstico , Degeneração Lobar Frontotemporal/diagnóstico , Doença de Alzheimer/sangue , Doença de Alzheimer/patologia , Atrofia/sangue , Atrofia/patologia , Biomarcadores/sangue , Encéfalo/patologia , Disfunção Cognitiva/sangue , Disfunção Cognitiva/patologia , Diagnóstico Diferencial , Progressão da Doença , Feminino , Demência Frontotemporal/sangue , Demência Frontotemporal/patologia , Degeneração Lobar Frontotemporal/sangue , Degeneração Lobar Frontotemporal/patologia , Humanos , Imageamento por Ressonância Magnética , Masculino , Testes Neuropsicológicos
2.
J Assist Reprod Genet ; 26(11-12): 557-60, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19921421

RESUMO

PURPOSE: To investigate whether follicular fluid lipid-soluble micronutrients are associated with embryo morphology parameters during IVF. METHODS: Follicle fluid and oocytes were obtained prospectively from 81 women. Embryo morphology parameters were used as surrogate markers of oocyte health. HDL lipids and lipid-soluble micronutrients were analyzed by high-pressure liquid chromatography. Non-parametric bi-variate analysis and multivariable ordinal logistic regression models were employed to examine associations between biochemical and embryo morphology parameters. RESULTS: Follicular fluid HDL cholesterol (r = -0.47, p < 0.01), alpha-tocopherol (r = -0.41, p < 0.01), delta-tocopherol (r = -0.38, p < 0.05) and beta-cryptoxanthine (r = -0.42, p < 0.01) are negatively correlated with embryo fragmentation. Ordinal logistic regression models indicate that a 0.1 mumol/L increase in beta-cryptoxanthine, adjusted for gamma-tocopherol, is associated with a 75% decrease in the cumulative odds of higher embryo fragmentation (p = 0.010). CONCLUSION: Follicular fluid HDL micronutrients may play an important role in the development of the human oocyte as evident by embryo fragmentation during IVF.


Assuntos
HDL-Colesterol/metabolismo , Embrião de Mamíferos/metabolismo , Líquido Folicular/metabolismo , Micronutrientes/metabolismo , Adulto , Embrião de Mamíferos/anatomia & histologia , Feminino , Fertilização in vitro/métodos , Humanos , Modelos Logísticos , Masculino , Análise Multivariada , Gravidez , Estudos Prospectivos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...